Steven Goldman
Principal investigator, leads Avery Therapeutics, Inc.
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$1.1MFederal grants as PI3 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $1.1M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 15, 2019 | NIH | SBIR Phase I Development and Assessment of an Engineered Cardiac Tissue for Treating Dilated Cardiomyopathy | $300K | Avery Therapeutics, Inc |
| May 15, 2019 | NIH | SBIR Phase I Development and Assessment of an Engineered Cardiac Tissue for Treating Dilated Cardiomyopathy | $300K | Avery Therapeutics, Inc |
| Aug 18, 2016 | NIH | SBIR Phase I HLS16-07: Manufacturing Tissue Engineered Patch to Treat Heart Failure | $484K | Avery Therapeutics, Inc |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#1,679
Awards as PI#822
Patents#273
Companies
- Avery Therapeutics, IncLeads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.